2013
DOI: 10.1111/jocs.12232
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes of Patients Undergoing Third-Time Aortic or Mitral Valve Replacement

Abstract: Third-time aortic or mitral valve replacement is a rare procedure but accompanied with high morbidity and mortality, especially in patients with prosthetic valve endocarditis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 25 publications
0
6
1
Order By: Relevance
“…Thirty-day mortality in patients with TAV-in-REDO SAV (4%) was lower than that reported after third-time SAVR (12% 4 –21.1% 3 ). The need for a second valve rate (8%) was relatively higher than that after TAV-in-SAV (4.6%) and after TAVR in native valve.…”
contrasting
confidence: 54%
“…Thirty-day mortality in patients with TAV-in-REDO SAV (4%) was lower than that reported after third-time SAVR (12% 4 –21.1% 3 ). The need for a second valve rate (8%) was relatively higher than that after TAV-in-SAV (4.6%) and after TAVR in native valve.…”
contrasting
confidence: 54%
“…Elhmidi et al reported on a 30-day mortality of 35%. 5 Strikingly better results were reported by Shaikhrezai et al with an in-hospital mortality rate of 4.1%. In this cohort of patients, more than 65% of the patients had undergone previous homograft placement.…”
Section: Discussionmentioning
confidence: 83%
“…Elhmidi et al reported on a mortality rate of 25%, and Expósito et al stated 18.8%. 5,16,17 Reported results for primary redo mitral surgery is associated with a nonuniform mortality rate similar to redo AVR. Kothari et al reported a total mortality of 29.2% for redo MVR.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thirty day and midterm mortality are reported to be 19% and 31% respectively in a small series of patients who underwent third-time valve surgery. 7) On the other hand, there have been reports of uneventful midterm-up to 5 years from diagnosis-follow up of uncomplicated MAIVF-Ps. 8) 9) Generally, a watchful waiting approach with serial imaging and referral for operation should complications or rapid expansion ensue, may be valid for asymptomatic patients with high operative risk.…”
Section: Discussionmentioning
confidence: 99%